Literature DB >> 10774102

[Effectiveness of acarbose in the control of glucose tolerance worsening in pregnancy].

A Zárate1, R Ochoa, M Hernández, L Basurto.   

Abstract

Gestational diabetes is considered as a carbohydrate intolerance, first diagnosed during pregnancy. A previous stage of carbohydrate impairement may precede its abnormality; therefore it may be convenient to establish some management in order to avoid the gestational diabetes. Six pregnant women who had moderate elevated level of blood glucose at fasting and postprandial were treated with acarbose, alpha-glucosidase inhibitor agent, given three times a day before meals. In all patients fasting and postprandial glucose levels were normalized; pregnancies went uneventful and the newborns were considered normal. Acarbose was associated with intestinal discomfort which persisted during the whole pregnancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10774102

Source DB:  PubMed          Journal:  Ginecol Obstet Mex        ISSN: 0300-9041


  10 in total

1.  Inhibitory effect and mechanism of acarbose combined with gymnemic acid on maltose absorption in rat intestine.

Authors:  H Luo; L F Wang; T Imoto; Y Hiji
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 2.  Oral Hypoglycemic Agents in pregnancy: An Update.

Authors:  Nagandla Kavitha; Somsubhra De; Sachchithanantham Kanagasabai
Journal:  J Obstet Gynaecol India       Date:  2013-03-27

Review 3.  Using oral agents to manage gestational diabetes: what have we learned?

Authors:  Elizabeth Buschur; Florence Brown; Jennifer Wyckoff
Journal:  Curr Diab Rep       Date:  2015-02       Impact factor: 4.810

Review 4.  The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy.

Authors:  Rachel A Blair; Emily A Rosenberg; Nadine E Palermo
Journal:  Curr Diab Rep       Date:  2019-12-06       Impact factor: 4.810

Review 5.  Safety considerations with pharmacological treatment of gestational diabetes mellitus.

Authors:  David Simmons
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

Review 6.  Drugs to Control Diabetes During Pregnancy.

Authors:  Maisa N Feghali; Jason G Umans; Patrick M Catalano
Journal:  Clin Perinatol       Date:  2019-03-26       Impact factor: 3.430

Review 7.  Pharmacological Management of Gestational Diabetes Mellitus.

Authors:  Geetha Mukerji; Denice S Feig
Journal:  Drugs       Date:  2017-10       Impact factor: 9.546

Review 8.  The use of oral antidiabetic medications in gestational diabetes mellitus.

Authors:  Michael J Paglia; Donald R Coustan
Journal:  Curr Diab Rep       Date:  2009-08       Impact factor: 4.810

9.  Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Authors:  Deborah J Wexler; Camille E Powe; Linda A Barbour; Thomas Buchanan; Donald R Coustan; Rosa Corcoy; Peter Damm; Fidelma Dunne; Denice S Feig; Assiamira Ferrara; Lorie M Harper; Mark B Landon; Sara J Meltzer; Boyd E Metzger; Hilary Roeder; Janet A Rowan; David A Sacks; David Simmons; Jason G Umans; Patrick M Catalano
Journal:  Obstet Gynecol       Date:  2018-08       Impact factor: 7.661

10.  Comparison of Fetomaternal Outcomes in Patients With Gestational Diabetes Mellitus Treated With Insulin Versus Acarbose: Results of a Prospective, Open Label, Controlled Study.

Authors:  Suryakanta Jayasingh; Saumya Nanda; Sujata Misra; A Baliarsinha; Sidhartha Das; Anant Patil
Journal:  Cureus       Date:  2020-12-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.